Multiple myeloma, also known as Kahler's disease, is a type of blood cancer. There's no cure, but treatments can slow its spread and sometimes make symptoms go away. A type of white blood cell called a plasma cell makes antibodies that fight infections in your body. When you have multi...
This is a cancer of the plasma cells in bone marrow. Plasma cells are a type of white blood cell that makes antibodies. Myeloma cells spread through the bone marrow. They can damage your bones and crowd out healthy blood cells. These cells also make antibodies that can't fight off infecti...
For patients newly diagnosed with multiple myeloma in Oregon's Willamette Valley, our team of blood cancer specialists can walk you through what to expect
000 people are diagnosed with multiple myeloma in the United States. Survival for a period of 5 years is seen in only 50% people. Genetic transformation ofplasma cells(a type of white blood cells concerned with immunity
The Pharmacy Times® Multiple Myeloma Resource Center is a comprehensive resource for clinical news and expert insights on issues related to cancer that forms in a type of white blood cell.
A small clinical trial has shown that a new drug has promise for targeting tumours in patients with an aggressive type of blood cancer. Multiplemyelomais a relatively rare type of cancer that develops in thebone marrow– the spongey tissue inside the bone where new blood cells are produced –...
Understanding Cancer cancer that involves a type of white blood cell called a plasma (or myeloma) cell. The tumor cells in myeloma can form a single collection (plasmacytoma) or many tumors (multiple myeloma). Plasma cells are normally part of theimmune system; they make antibodies. Because ...
New Drug Shows Potential for Blood Cancer; Multiple Myeloma Patients Saw Survival Gains When Elotuzumab Was Added to TreatmentThompson, Dennis
Medicine and section chief of hematology at Perlmutter Cancer Center, said in a press release. “Her work has been fundamental to revealing the importance of achieving complete remission inmyeloma therapy, and under her leadership, the center is poised to extend treatment adv...
Multiple Myeloma By Julia Cipriano, MS/September 2024 Delays in Oral Antimyeloma Treatment Initiation: Role of Social Determinants of Health A retrospective cohort study published in Blood Cancer Journal by Gasoyan et al revealed discrepancies between the timing of the initiation of any treatment and...